Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ralph Edwards

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 2, 2010
Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern?Kristina Star, Andrew Bate, Ronald Hb Meyboom, et al.
Drug Safety|October 9, 2008
Impact of stratification on adverse drug reaction surveillanceJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
Drug Safety|November 26, 2008
Stratification for spontaneous report databasesJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
BMC Pharmacology & Toxicology|March 19, 2013
Attitudes among healthcare professionals to the reporting of adverse drug reactions in NepalK C Santosh, Pramote Tragulpiankit, Sarun Gorsanan, et al.
Statistics in Medicine|March 18, 2008
A statistical methodology for drug-drug interaction surveillanceG Niklas Norén, Rolf Sundberg, Andrew Bate, et al.
Drug Safety|April 26, 2011
Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBaseKristina Star, G Niklas Norén, Karin Nordin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 1, 2012
Quantitative benefit-risk assessment using only qualitative information on utilitiesOla Caster, G Niklas Norén, Love Ekenberg, et al.
Drug Safety|February 22, 2011
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBaseJohanna Strandell, Ola Caster, Andrew Bate, et al.
Drug Safety|July 17, 2003
Assessing the impact of drug safety signals from the WHO database presented in 'SIGNAL': results from a questionnaire of National pharmacovigilance CentresMalin Ståhl, I Ralph Edwards, Geoffrey Bowring, et al.
Pharmacoepidemiology and Drug Safety|January 28, 2015
Longitudinal medical records as a complement to routine drug safety signal analysisKristina Star, Sarah Watson, Lovisa Sandberg, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 2, 2010
Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern?Kristina Star, Andrew Bate, Ronald Hb Meyboom, et al.
Drug Safety|October 9, 2008
Impact of stratification on adverse drug reaction surveillanceJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
Drug Safety|November 26, 2008
Stratification for spontaneous report databasesJohan Hopstadius, G Niklas Norén, Andrew Bate, et al.
BMC Pharmacology & Toxicology|March 19, 2013
Attitudes among healthcare professionals to the reporting of adverse drug reactions in NepalK C Santosh, Pramote Tragulpiankit, Sarun Gorsanan, et al.
Statistics in Medicine|March 18, 2008
A statistical methodology for drug-drug interaction surveillanceG Niklas Norén, Rolf Sundberg, Andrew Bate, et al.
Drug Safety|April 26, 2011
Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBaseKristina Star, G Niklas Norén, Karin Nordin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 1, 2012
Quantitative benefit-risk assessment using only qualitative information on utilitiesOla Caster, G Niklas Norén, Love Ekenberg, et al.
Drug Safety|February 22, 2011
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBaseJohanna Strandell, Ola Caster, Andrew Bate, et al.
Drug Safety|July 17, 2003
Assessing the impact of drug safety signals from the WHO database presented in 'SIGNAL': results from a questionnaire of National pharmacovigilance CentresMalin Ståhl, I Ralph Edwards, Geoffrey Bowring, et al.
Pharmacoepidemiology and Drug Safety|January 28, 2015
Longitudinal medical records as a complement to routine drug safety signal analysisKristina Star, Sarah Watson, Lovisa Sandberg, et al.
Pageof 10